GLP-1
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Certain tortillas are now being marketed as ‘GLP-1 friendly.’ What does that even mean?
Certain tortillas are now being marketed as ‘GLP-1 friendly.’ What does that even mean? While a ‘GLP-1 friendly’ label may seem arbitrary, some medical experts say it may make people pay closer attention to what they’re eating - Bookmark - CommentsGo to comments Food manufacturers are trying to cash in on the popularity of weight-loss medications such as Ozempic and Mounjaro, with a growing number of easy, grab-and-go meals and snacks being sold as “GLP-1 friendly.”
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm any anti-cancer benefit. A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen studies presented over the...
Dr Amir Khan speaks out on GLP-1 weight loss jabs and 'cheating' claims
Dr Amir Khan speaks out on GLP-1 weight loss jabs and 'cheating' claims A doctor has called for a change in how people view GLP-1 weight loss jabs A doctor has shared his "little rant" about people who use weight loss jabs. He insisted that doing so is "not cheating".
Mayim Bialik details 'nightmare' after one injection of GLP-1 drug led to weeks of debilitating side effects
Mayim Bialik is speaking out candidly about a severe reaction she says she experienced after taking a GLP-1 medication, revealing that a single low-dose injection led to weeks of debilitating gastrointestinal symptoms. In an essay that she penned for The Free Press titled "My GLP-1 Nightmare," the 50-year-old actress admitted that she had grappled with body image issues since she was a teenager but emphasized that weight loss was not her primary reason for taking the medication. "I went on a...
Scientists discover why ozempic may not work for some people
Scientists discover why ozempic may not work for some people A hidden genetic quirk may be making some people surprisingly resistant to the benefits of blockbuster GLP-1 diabetes drugs. - Date: - June 5, 2026 - Source: - Stanford Medicine - Summary: - Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes.
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare for the next sea change in how patients receive their drugs. Novo Nordisk on Sunday announced that prescriptions of the Wegovy pill have topped 3 million since it entered the U.S. market about five months ago. The Danish drugmaker's CEO Mike Doustdar celebrated the milestone, saying in an interview with CNBC that Novo was able to accelerate prescriptions even as Lilly...
Withings Debuts New Smart Scale Marketed Toward GLP-1 Users
Withings unveiled a new model with advanced body composition scanning abilities that is being marketed toward people on popular GLP-1 weight loss drugs.
The Wegovy pill is still dominating the GLP-1 pill market
It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and...
What do you mean my new smart scale is ‘built for GLP-1 users’?
This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life. Opt in for Optimizer here. A few days ago, I walked into the basement of a midtown gym.